Canada
26
2018-09-27
26
2019-11-19
These are the the leading inventors for applications assigned to Endorecherche, Inc.:
Endorecherche, Inc. based in , CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Sex steroid precursors alone or in combination with selective estrogen receptor modulators for the prevention and treatment of sexual dysfunction in postmenopausal women
#2 | 2017-10-12 β Patent 10,548,903 granted on 2020-02-04Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM
#3 | 2016-03-03 β Patent 10,076,525 granted on 2018-09-18Sex steroid precursors alone or in combination with selective estrogen receptor modulators for the prevention and treatment of dyspareunia in postmenopausal women
#4 | 2015-09-10 β Patent 9,744,177 granted on 2017-08-29Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM
#5 | 2015-06-25 β Patent 9,682,960 granted on 2017-06-20Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety
#6 | 2013-12-17 β Patent 8,609,695 granted on 2013-12-17Methods of treating and/or suppressing insulin resistance
#7 | 2013-09-19 β Patent 10,342,805 granted on 2019-07-09Treatment of Alzheimer's disease, loss of cognition, memory loss and dementia with sex steroid precursors in combination with selective estrogen receptor modulators
#8 | 2013-01-03 β Patent 8,629,129 granted on 2014-01-14Pharmaceutical compositions
#9 | 2012-12-20 β Patent 10,881,650 granted on 2021-01-05Pharmaceutical compositions
#10 | 2012-11-08 β Patent 8,957,054 granted on 2015-02-17Pharmaceutical compositions
#11 | 2010-09-09 β Patent 8,168,627 granted on 2012-05-01Helix 12 directed non-steroidal antiandrogens
#12 | 2009-02-26 β Patent 8,268,806 granted on 2012-09-18Pharmaceutical compositions
#13 | 2009-02-12 β Patent 9,284,345 granted on 2016-03-1517alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
#14 | 2008-09-30 β Patent 7,429,576 granted on 2008-09-30Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
#15 | 2007-11-22 β Patent 8,835,413 granted on 2014-09-16Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cGMP phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
#16 | 2007-02-01 β Patent 7,943,603 granted on 2011-05-17Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
#17 | 2007-02-01 β Patent 7,884,092 granted on 2011-02-08Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
#18 | 2007-02-01 β Patent 8,188,066 granted on 2012-05-29Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
#19 | 2006-12-21 β Patent 7,709,516 granted on 2010-05-04Helix 12 directed non-steroidal antiandrogens
#20 | 2006-02-28 β Patent 7,005,428 granted on 2006-02-28Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
#21 | 2006-02-07 β Patent 6,995,150 granted on 2006-02-07Pharmaceutical compositions and uses for androst-5-ene-3Ξ², 17Ξ²-diol
#22 | 2005-11-15 β Patent 6,964,955 granted on 2005-11-15Pharmaceutical compositions and uses for androst-5-ene-3Ξ², 17Ξ²-diol
#23 | 2005-11-10 β Patent 9,090,651 granted on 2015-07-28Helix 12 directed pharmaceutical products
#24 | 2005-08-23 β Patent 6,933,321 granted on 2005-08-23Antiandrogenic biphenyls
#25 | 2005-06-23 β Patent 8,389,548 granted on 2013-03-05Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
#26 | 2005-04-26 β Patent 6,884,795 granted on 2005-04-26Pharmaceutical compositions and uses for androst-5-ene-3Ξ², 17Ξ²-diol
426208 β